Identification of genetically engineered strategies to manipulate nano-platforms presenting immunotherapeutic ligands for alleviating primary ovarian insufficiency progression
Abstract Primary ovarian insufficiency (POI) is a pathological condition characterized by the early loss of functional ovarian follicles, leading to infertility and systemic consequences affecting reproductive, skeletal, cardiovascular, and neurocognitive helath. Aberrant immune activation, particul...
Saved in:
| Main Authors: | Guannan Zhou, Yuanyuan Gu, Menglei Zhang, Jingxin Ding, Guanming Lu, Keqin Hua, Fang Shen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Cell Communication and Signaling |
| Online Access: | https://doi.org/10.1186/s12964-025-02226-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapy
by: Menglei Zhang, et al.
Published: (2025-05-01) -
Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency
by: Shao Yang, et al.
Published: (2025-08-01) -
NanoSSIEFARL polymeric nanoparticles-based immunotherapeutic for the treatment of genital herpes
by: Renata Zorzetto, et al.
Published: (2025-04-01) -
Pharmacological Evaluation of Polygoni Multiflori Radix Praeparata Extract: Inhibition of PANoptosis in Alleviating Premature Ovarian Insufficiency
by: Can Zhu, et al.
Published: (2025-07-01) -
Premature ovarian insufficiency in patients with galactosemia
by: Irina V. Karachentsova, et al.
Published: (2024-05-01)